Important: TC Application Procedure for All Students
Rank List of Candidates For Faculty Positions In Various Departments of Self Financing Section
Schedule of Walk-in Interviews (Govt. Guest Lecturer)
Sacred Heart College Honoured at Education World Rankings 2025 Ceremony
SH School of Communication – Admissions Open!
Globally, as of 29 November 2020, there have been 61,869,330 confirmed cases of COVID-19, including 1,448,896 deaths, reported to WHO.
COVID – 19 in India
Active – 446952
Deaths – 137139 (1.45%)
COVID – 19 in Kerala
Active – 64589
Deaths – 2223 (0.37%)
COVID-19 vaccine
Researchers worldwide are working around the clock to find a vaccine against SARS-CoV-2, the virus causing the COVID-19 pandemic. The Herculean effort means that a fast-tracked vaccine could come to market anywhere from the end of 2020 to the middle of 2021.
To date, just two coronavirus vaccine has been approved. Sputnik V – formerly known as Gam-COVID-Vac and developed by the Gamaleya Research Institute in Moscow – was approved by the Ministry of Health of the Russian Federation on 11 August. Experts have raised considerable concern about the vaccine’s safety and efficacy given it has not yet entered Phase 3 clinical trials. A second vaccine in Russia, EpiVacCorona, has also been granted regulatory approval, also without entering Phase 3 clinical trials.